Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats

K. Tanaka, F. Gotoh, Y. Fukuuchi, T. Amano, N. Suzuki, D. Uematsu, J. Kawamura, T. Yamawaki, N. Itoh, K. Obara

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We evaluated the effect of a stable synthetic prostacyclin analogue, TRK-100, on the microcirculatory derangement occurring in feline pial vessels with endothelial damage after middle cerebral artery occlusion. Fifteen adult cats were divided into an untreated group (Group 1, n = 8) and a treated group (Group 2, n = 7). Thirty minutes after 10 minutes of ultraviolet irradiation, which selectively damaged endothelium in the pial vessels, the middle cerebral artery was occluded in both groups and maintained for 30 minutes. In Group 2, 50 ng/kg/min TRK-100 was continuously infused intravenously following ultraviolet irradiation. In both the pial arteries and veins, platelet aggregate adhesion to the endothelium with subsequent thrombus formation was significantly (p < 0.01 and p < 0.05, respectively) inhibited during middle cerebral artery occlusion in Group 2 compared with Group 1. Similarly, blood flow stasis in the pial veins was effectively prevented in Group 2 during occlusion. Furthermore, the pial artery diameter returned to the control level during the late period of occlusion, whereas in Group 1 the pial artery remained constricted. Our data suggest that TRK-100 can prevent microcirculatory derangement in the acute stage of ischemic stroke.

Original languageEnglish
Pages (from-to)1267-1274
Number of pages8
JournalStroke
Volume19
Issue number10
Publication statusPublished - 1988

Fingerprint

beraprost
Epoprostenol
Brain Ischemia
Cerebral Veins
Cats
Arteries
Middle Cerebral Artery Infarction
Endothelium
Felidae
Middle Cerebral Artery
Thrombosis
Blood Platelets
Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Tanaka, K., Gotoh, F., Fukuuchi, Y., Amano, T., Suzuki, N., Uematsu, D., ... Obara, K. (1988). Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats. Stroke, 19(10), 1267-1274.

Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats. / Tanaka, K.; Gotoh, F.; Fukuuchi, Y.; Amano, T.; Suzuki, N.; Uematsu, D.; Kawamura, J.; Yamawaki, T.; Itoh, N.; Obara, K.

In: Stroke, Vol. 19, No. 10, 1988, p. 1267-1274.

Research output: Contribution to journalArticle

Tanaka, K, Gotoh, F, Fukuuchi, Y, Amano, T, Suzuki, N, Uematsu, D, Kawamura, J, Yamawaki, T, Itoh, N & Obara, K 1988, 'Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats', Stroke, vol. 19, no. 10, pp. 1267-1274.
Tanaka K, Gotoh F, Fukuuchi Y, Amano T, Suzuki N, Uematsu D et al. Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats. Stroke. 1988;19(10):1267-1274.
Tanaka, K. ; Gotoh, F. ; Fukuuchi, Y. ; Amano, T. ; Suzuki, N. ; Uematsu, D. ; Kawamura, J. ; Yamawaki, T. ; Itoh, N. ; Obara, K. / Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats. In: Stroke. 1988 ; Vol. 19, No. 10. pp. 1267-1274.
@article{0b574039a42f4db18569ffbed9602d77,
title = "Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats",
abstract = "We evaluated the effect of a stable synthetic prostacyclin analogue, TRK-100, on the microcirculatory derangement occurring in feline pial vessels with endothelial damage after middle cerebral artery occlusion. Fifteen adult cats were divided into an untreated group (Group 1, n = 8) and a treated group (Group 2, n = 7). Thirty minutes after 10 minutes of ultraviolet irradiation, which selectively damaged endothelium in the pial vessels, the middle cerebral artery was occluded in both groups and maintained for 30 minutes. In Group 2, 50 ng/kg/min TRK-100 was continuously infused intravenously following ultraviolet irradiation. In both the pial arteries and veins, platelet aggregate adhesion to the endothelium with subsequent thrombus formation was significantly (p < 0.01 and p < 0.05, respectively) inhibited during middle cerebral artery occlusion in Group 2 compared with Group 1. Similarly, blood flow stasis in the pial veins was effectively prevented in Group 2 during occlusion. Furthermore, the pial artery diameter returned to the control level during the late period of occlusion, whereas in Group 1 the pial artery remained constricted. Our data suggest that TRK-100 can prevent microcirculatory derangement in the acute stage of ischemic stroke.",
author = "K. Tanaka and F. Gotoh and Y. Fukuuchi and T. Amano and N. Suzuki and D. Uematsu and J. Kawamura and T. Yamawaki and N. Itoh and K. Obara",
year = "1988",
language = "English",
volume = "19",
pages = "1267--1274",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats

AU - Tanaka, K.

AU - Gotoh, F.

AU - Fukuuchi, Y.

AU - Amano, T.

AU - Suzuki, N.

AU - Uematsu, D.

AU - Kawamura, J.

AU - Yamawaki, T.

AU - Itoh, N.

AU - Obara, K.

PY - 1988

Y1 - 1988

N2 - We evaluated the effect of a stable synthetic prostacyclin analogue, TRK-100, on the microcirculatory derangement occurring in feline pial vessels with endothelial damage after middle cerebral artery occlusion. Fifteen adult cats were divided into an untreated group (Group 1, n = 8) and a treated group (Group 2, n = 7). Thirty minutes after 10 minutes of ultraviolet irradiation, which selectively damaged endothelium in the pial vessels, the middle cerebral artery was occluded in both groups and maintained for 30 minutes. In Group 2, 50 ng/kg/min TRK-100 was continuously infused intravenously following ultraviolet irradiation. In both the pial arteries and veins, platelet aggregate adhesion to the endothelium with subsequent thrombus formation was significantly (p < 0.01 and p < 0.05, respectively) inhibited during middle cerebral artery occlusion in Group 2 compared with Group 1. Similarly, blood flow stasis in the pial veins was effectively prevented in Group 2 during occlusion. Furthermore, the pial artery diameter returned to the control level during the late period of occlusion, whereas in Group 1 the pial artery remained constricted. Our data suggest that TRK-100 can prevent microcirculatory derangement in the acute stage of ischemic stroke.

AB - We evaluated the effect of a stable synthetic prostacyclin analogue, TRK-100, on the microcirculatory derangement occurring in feline pial vessels with endothelial damage after middle cerebral artery occlusion. Fifteen adult cats were divided into an untreated group (Group 1, n = 8) and a treated group (Group 2, n = 7). Thirty minutes after 10 minutes of ultraviolet irradiation, which selectively damaged endothelium in the pial vessels, the middle cerebral artery was occluded in both groups and maintained for 30 minutes. In Group 2, 50 ng/kg/min TRK-100 was continuously infused intravenously following ultraviolet irradiation. In both the pial arteries and veins, platelet aggregate adhesion to the endothelium with subsequent thrombus formation was significantly (p < 0.01 and p < 0.05, respectively) inhibited during middle cerebral artery occlusion in Group 2 compared with Group 1. Similarly, blood flow stasis in the pial veins was effectively prevented in Group 2 during occlusion. Furthermore, the pial artery diameter returned to the control level during the late period of occlusion, whereas in Group 1 the pial artery remained constricted. Our data suggest that TRK-100 can prevent microcirculatory derangement in the acute stage of ischemic stroke.

UR - http://www.scopus.com/inward/record.url?scp=0023711350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023711350&partnerID=8YFLogxK

M3 - Article

C2 - 3051533

AN - SCOPUS:0023711350

VL - 19

SP - 1267

EP - 1274

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 10

ER -